You are here: Industry Insights > Covishield

News List

Nepal, Bangladesh get COVID-19 vaccine consignments from India expresspharma
January 22, 2021
India on Thursday delivered two million doses of Covishield vaccines to Bangladesh and one million doses to Nepal under grants assistance.
Bhutan and Maldives get COVID-19 vaccines sent from India expresspharma
January 21, 2021
1,50,000 doses of Covishield vaccine, manufactured by SII, were sent to Bhutan and 1,00,000 doses reached Maldives.
Serum Institute issues factsheet for Covishield expresspharma
January 20, 2021
Serum Institute of India (SII) has issued a factsheet of Covishield which includes details of the ingredients used in the COVID-19 vaccine.
Covishield to dominate overall COVID-19 vaccination drive in India: GlobalData expresspharma
January 18, 2021
SII has taken the lead in supplying orders for the Indian government through 11 million doses ordered of Covishield versus 5.5 million doses of Covaxin.
Recipients cannot choose between two COVID vaccine options for now: GoI expresspharma
January 13, 2021
1.1 crore doses of Covishield from the Serum Institute of India and 55 lakh doses of Covaxin from Bharat Biotech - will be received by January 14, informed Rajesh Bhushan, Union Health Secretary.
SII receives purchase order from Government of India for 11 million doses of Covishield expresspharma
January 12, 2021
The government placed a purchase order with Serum Institute of India (SII) for 11 million doses of Oxford COVID-19 vaccine, Covishield, each dose costing Rs 210 including GST, official sources said.
Mixed reactions from healthcare experts, activists over REU for Covaxin, Covishield expresspharma
January 05, 2021
Some ask for more transparency in the approval process and seek data related to vaccine trials while others say that grant of REU in clinical trial mode in an emergency situation is in public interest.
DCGI approves Covishield and Covaxin for restricted emergency use in India expresspharma
January 04, 2021
DCGI’s decision comes after the Subject Expert Committee of CDSCO met on January 1-2, 2021 and recommended the grant of permission for restricted emergency use of these vaccines.
Awaiting India’s approval for COVISHIELD: SII expresspharma
December 31, 2020
The company made this statement after UK's approval of the Oxford-AstraZeneca COVID-19 vaccine.
Covishield can be available in first half of 2021 expresspharma
December 14, 2020
Serum Institute has currently applied with the DCGI for emergency authorization of Covishield in the country.

Previous page 1 2 3 4 5 Next page